Masters Capital Management’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Masters Capital Management’s Portfolio TMDI Stock Details TMDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,500,000	Closed	-$2.28M	–	80
2021 Q3	$2.28M	Buy	1,500,000 +500,000	+50%	+$812K	0.09%	68
2021 Q2	$1.71M	Buy	+1,000,000	New	+$1.72M	0.05%	65
2021 Q1	–	Sell	-1,250,000	Closed	-$2.14M	–	86
2020 Q4	$2.14M	Sell	1,250,000 -250,000	-17%	-$248K	0.13%	56
2020 Q3	$1.1M	Hold	1,500,000	–	–	0.07%	47
2020 Q2	$1.25M	Buy	1,500,000 +415,860	+38%	+$213K	0.14%	44
2020 Q1	$293K	Sell	1,084,140 -15,700	-1%	-$6.25K	0.03%	50
2019 Q4	$544K	Sell	1,099,840 -72,600	-6%	-$44.6K	0.03%	49
2019 Q3	$1.27M	Sell	1,172,440 -77,560	-6%	-$162K	0.08%	56
2019 Q2	$2.95M	Hold	1,250,000	–	–	0.14%	55
2019 Q1	$3.5M	Buy	1,250,000 +250,000	+25%	+$819K	0.19%	57
2018 Q4	$1.22M	Hold	1,000,000	–	–	0.07%	52
2018 Q3	$2.13M	Buy	+1,000,000	New	+$2.83M	0.05%	74

Other funds holding TMDI

Essex LLC Deer Park, Illinois $659M AUM 41.98% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

CCG

Ceeto Capital Group Coral Gables, Florida $369M AUM 34.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Masters Capital Management's TMDI Position: Q4 2021 in Review

Masters Capital Management sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q4 2021, closing a stake of 1,500,000 shares — an estimated $2.28M sold.

Masters Capital Management first reported a position in TMDI in Q3 2018 and held it in 12 quarters. The position peaked at $3.5M in Q1 2019. 60 funds tracked by Wall St. Rank hold TMDI as of Q4 2021.

Masters Capital Management reported no remaining Titan Medical Inc. Ordinary Shares position as of Q4 2021 after selling out during the quarter.
Masters Capital Management sold 1,500,000 Titan Medical Inc. Ordinary Shares shares in Q4 2021, an estimated $2.28M.
Masters Capital Management first reported a position in Titan Medical Inc. Ordinary Shares in Q3 2018 and held it in 12 quarters.
Masters Capital Management's Titan Medical Inc. Ordinary Shares position peaked at $3.5M in Q1 2019.
60 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q4 2021.

Based on Masters Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.